Helmholtz Diabetes Center Institute of Diabetes Research and Metabolic Diseases (IDM)
The primary research goal of the Institute of Diabetes Research and Metabolic Diseases is the individualized prediction of diabetes risk and diabetes prevention and its personalized therapy.
The primary research goal of the Institute of Diabetes Research and Metabolic Diseases is the individualized prediction of diabetes risk and diabetes prevention and its personalized therapy.
Recent Publications
2022 Metabolites 10.3390/metabo13010015
2023 International Journal of Obesity https://doi.org/10.1038/s41366-023-01271-y
2022 Biology Open https://doi.org/10.1242/bio.059403
2022 Current Medicinal Chemistry 10.2174/0929867329666220608162256
2022 Diabetes, Obesity and Metabolism https://doi.org/10.1111/dom.14733
2022 Acta Physiologica https://doi.org/10.1111/apha.13844
Rodent models to study sodium retention in experimental nephrotic syndrome.
2022 Diabetologie und Stoffwechsel https://doi.org/10.1007/s12181-022-00562-4
2022 Diabetologie, Die
2022 Hormone and Metabolic Research 10.1055/a-1834-9008
2022 PLoS ONE https://doi.org/10.1371/journal.pone.0267258
2022 International Journal of Obesity https://doi.org/10.1038/s41366-022-01115-1
2022 Journal of Clinical Endocrinology & Metabolism, The 10.1210/clinem/dgac179
Spotlight on the human brain - central actions of SGLT2 inhibitors?